Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, National Clinical Center for Oral Disease, Shanghai 200011, PR China.
Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, National Clinical Center for Oral Disease, Shanghai 200011, PR China.
Oral Oncol. 2020 Mar;102:104507. doi: 10.1016/j.oraloncology.2019.104507. Epub 2019 Dec 30.
To evaluate the oncological safety and reliability of the submental island flap (SIF) technique in patients with pathologically node-negative (pN0) and node-positive (pN+) T1-2 oral squamous cell carcinoma (OSCC) undergoing surgical tumor resection and concurrent SIF reconstruction.
Retrospectively, we reviewed patients with pN0 and pN+ T1-2 OSCC who underwent tumor resection and defect reconstruction with SIF from April 2008 to September 2016, focusing on flap viability, patterns and predictors of locoregional failure, salvage treatments, and oncologic prognosis.
Of 160 patients with primary T1-2 OSCC, 33 were pN+ and 127 were pN0. All SIFs beside two were successful (98.75%). During follow-up, 18 patients experienced locoregional tumor relapse, of which 14 were pN0 and four were pN+. The 5-year recurrence-free survival was 88.73% vs. 86.93% for the pN0 and pN+ groups, respectively (p = .847). The pN + patients had poorer prognosis than pN0 patients (5-year overall survival, 66.35% vs. 91.10% respectively [p = .005]; disease-specific survival, 74.87% vs. 91.88% respectively [p = .016]). Multivariate analyses indicated there was no independent predictor for locoregional recurrence, but pN+ was predictive for poor prognosis (p = .03).
SIF is a reliable flap for the reconstruction of OSCC-related small- and medium-sized soft tissue defect. With careful neck dissection and appropriate postoperative adjuvant treatment, the application of SIF did not increase the risk of locoregional tumor recurrence in patients with pN+ T1-2 OSCC compared with those with pN0 T1-2 OSCC.
评估颏下岛状皮瓣(SIF)技术在病理淋巴结阴性(pN0)和淋巴结阳性(pN+)T1-2 口腔鳞状细胞癌(OSCC)患者中的肿瘤安全性和可靠性,这些患者接受手术肿瘤切除和同期 SIF 重建。
回顾性分析 2008 年 4 月至 2016 年 9 月接受肿瘤切除和 SIF 缺损重建的 pN0 和 pN+T1-2 OSCC 患者,重点关注皮瓣存活率、局部区域失败的模式和预测因素、挽救治疗和肿瘤学预后。
在 160 例原发性 T1-2 OSCC 患者中,33 例为 pN+,127 例为 pN0。所有 SIF 除 2 例外均成功(98.75%)。在随访期间,18 例患者出现局部区域肿瘤复发,其中 14 例为 pN0,4 例为 pN+。pN0 组和 pN+组的 5 年无复发生存率分别为 88.73%和 86.93%(p=0.847)。pN+患者的预后较 pN0 患者差(5 年总生存率分别为 66.35%和 91.10%[p=0.005];疾病特异性生存率分别为 74.87%和 91.88%[p=0.016])。多因素分析表明,局部区域复发无独立预测因素,但 pN+是预后不良的预测因素(p=0.03)。
SIF 是一种可靠的皮瓣,可用于重建与 OSCC 相关的小型和中型软组织缺损。对于 pN+T1-2 OSCC 患者,与 pN0 T1-2 OSCC 患者相比,在进行仔细的颈部解剖和适当的术后辅助治疗后,应用 SIF 不会增加局部区域肿瘤复发的风险。